CD274 and neoplasm: In previous studies, it remains controversial whether blood-based CD274 assay results can reflect mutations or PD-L1 expression difference in-situ tumor tissue due to blood CTC-based PD-L1 assay relies on ELISA and qPCR techniques [12].